How to Review a Research Peptide Certificate of Analysis

This note is for qualified laboratory researchers who must evaluate Certificates of Analysis (COAs) for research peptides. It focuses on the analytical and documentation items to verify, how to interpret common data outputs, and which records to request for traceability and repeatability. It does not provide any guidance on use or administration.

Key COA elements to verify

• Identity: Confirm sequence and molecular formula are provided. Check reported mass spectral ions (e.g., [M+H]+, [M+2H]2+) against the theoretical monoisotopic mass. High-resolution mass spectrometry should report mass error in ppm.
• Purity specification: Verify assay/purity results (typically % by HPLC). Note the assay basis (area%, corrected area%, or weight%) and stated acceptance criteria.
• Salt/counter-ion and free-base form: COA should state counter-ions (e.g., trifluoroacetate, acetate) and whether purity is reported on a salt- or peptide-basis; this affects calculated mass and % w/w.
• Water content and residual solvents: Water (Karl Fischer) and residual solvent analyses affect peptide mass balance and stability assessments.
• Impurity profile: Check chromatographic profiles and reported identity of major impurities (retention times, relative areas) and acceptance thresholds.
• Storage, expiry, and batch number: Confirm storage conditions, manufacture date, batch/lot number, and assigned expiry or retest date.

Analytical data and interpretation

Request raw analytical outputs rather than summary tables when possible. Typical items include:

• HPLC/UPLC chromatograms: Look for clear peak shape, baseline resolution, integration parameters (thresholds, smoothing), and system suitability results (tailing factor, theoretical plates).
• Mass spectra: For HRMS, verify measured m/z, charge state assignment, and ppm error. A commonly expected HRMS mass error for small peptides is within a few ppm; acceptance depends on the instrument and method validation.
• MS/MS or sequencing data: Fragmentation spectra (b/y ions) supporting sequence assignment are preferred for unambiguous identity confirmation.
• Spectrophotometric or amino acid analysis: If used for assay, confirm method details and calibration; report linearity (R2) and limits of quantitation.

When interpreting chromatograms and spectra, cross-check peak assignments against provided reference standards and retention-time windows. Note whether peak purity algorithms were applied and the settings used.

Documentation, traceability and regulatory considerations

• Method information: COAs should cite analytical methods (e.g., HPLC method ID, column, eluent, gradient, MS settings). For reproducibility, request the validated method or validation summary (specificity, accuracy, precision, LOQ/LOD).
• Raw data and audit trail: Ask for electronic raw data files and audit trails showing who executed and reviewed analyses. For regulated environments, confirm compliance with electronic records requirements (e.g., 21 CFR Part 11 where applicable).
• Certificate versioning: Ensure the COA includes version or revision number, issuer identity, signature/date, and a contact for technical queries.
• Reference standards and calibration: Document the reference material identity, purity, supplier, and certificates for reference standards used in assays or system suitability tests.

Red flags and follow-up actions

• If raw chromatograms or spectra are not available, request them before acceptance.
• Large mass errors, unexplained major impurities, or unspecified counter-ions warrant inquiry and potentially additional testing (e.g., orthogonal identity confirmation).
• Discrepancies between reported assay basis and declaration of salt form can produce incorrect % w/w; recalculate theoretical mass and percent if needed.
• Missing method validation parameters or lack of system suitability results should prompt a request for method validation summaries or re-analysis.

For further technical background on peptide testing approaches and method considerations, consult the United States Pharmacopeia guidance on peptides and a recent review of peptide analytical strategies: United States Pharmacopeia: https://www.usp.org/biologics/peptides; Analytical review: https://pmc.ncbi.nlm.nih.gov/articles/PMC10338602/.

Maintain a documented acceptance workflow in your laboratory that specifies which COA elements must be present for release, who is authorized to review and approve, and how deviations are escalated and documented.

Not for human consumption. For laboratory research use only.